D-0874-2026 Class II Ongoing
FDA drug recall D-0874-2026 was initiated by Aurolab Trust on Sep 17, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 25,220 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 7, 2026
- Initiation Date
- Sep 17, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25,220 bottles
Product description
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
VA
Code information
Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0874-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026